landiolol has been researched along with natriuretic peptide, brain in 2 studies
| Studies (landiolol) | Trials (landiolol) | Recent Studies (post-2010) (landiolol) | Studies (natriuretic peptide, brain) | Trials (natriuretic peptide, brain) | Recent Studies (post-2010) (natriuretic peptide, brain) |
|---|---|---|---|---|---|
| 311 | 85 | 176 | 16,317 | 1,867 | 8,887 |
| Protein | Taxonomy | landiolol (IC50) | natriuretic peptide, brain (IC50) |
|---|---|---|---|
| Atrial natriuretic peptide receptor 1 | Homo sapiens (human) | 0.006 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hata, M; Hirayama, A; Kunimoto, S; Nakai, T; Sezai, A; Shiono, M; Yoshitake, I | 1 |
| Arakawa, S; Kawano, H; Maemura, K; Matsumoto, Y; Sato, O; Yamasa, T | 1 |
1 trial(s) available for landiolol and natriuretic peptide, brain
| Article | Year |
|---|---|
Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting: a pilot study.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Antioxidants; Arginine; Atrial Fibrillation; Biomarkers; Bisoprolol; C-Reactive Protein; Coronary Artery Bypass; Creatine Kinase, MB Form; Drug Administration Schedule; Fatty Acid Binding Protein 3; Fatty Acid-Binding Proteins; Female; Hemodynamics; Humans; Infusions, Intravenous; Japan; Male; Middle Aged; Morpholines; Natriuretic Peptide, Brain; Pilot Projects; Serum Amyloid P-Component; Single-Blind Method; Time Factors; Treatment Outcome; Troponin I; Urea | 2012 |
1 other study(ies) available for landiolol and natriuretic peptide, brain
| Article | Year |
|---|---|
We need more useful surrogate markers for the efficacy of beta-blockers for the treatment of Takotsubo cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Female; Humans; Infusions, Intravenous; Morpholines; Natriuretic Peptide, Brain; Prognosis; Recovery of Function; Takotsubo Cardiomyopathy; Treatment Outcome; Troponin I; Urea | 2018 |